Company Filing History:
Years Active: 2021
Title: The Innovations of Julien Mahieux
Introduction
Julien Mahieux is an accomplished inventor based in Ecoteaux, Switzerland. He has made significant contributions to the field of chemistry, particularly in the resolution of chiral compounds. His work focuses on the production of pure enantiomers, which are crucial in various pharmaceutical applications.
Latest Patents
Julien Mahieux holds a patent for a "Method for resolution of baclofen salts." This invention pertains to the resolution of chiral compounds that exist as two optical antipodes, specifically Baclofen. The patent details the production of the pure enantiomer (R)(−) Baclofen, known chemically as (R)-4-amino-3-(4-chlorophenyl)-butanoic acid, along with its hydrogen maleate salt. The method described involves the resolution of hydrogen maleate salts of racemic Baclofen through preferential crystallization, particularly utilizing the AS3PC method, which stands for auto-seeded and programmed polythermal preferential crystallization.
Career Highlights
Throughout his career, Julien has worked with esteemed institutions, including the University of Rouen. His research has contributed to advancements in the field of chiral resolution, enhancing the understanding and production of important pharmaceutical compounds.
Collaborations
Julien Mahieux has collaborated with notable professionals in his field, including Gérard Coquerel and François-Xavier Gendron. These collaborations have further enriched his research and innovations.
Conclusion
Julien Mahieux's work in the resolution of chiral compounds exemplifies the importance of innovation in the pharmaceutical industry. His contributions continue to influence the development of effective medications.